This course will be held from Tuesday 7th to Thursday 9th May in the Clinical Neuroscience Lecture Theatre, Lower ground, 33 Queen Square, London WC1N 3B
REGISTRATION (right click and select - open in new window or open in new tab)
The Hereditary Sensory Neuropathy Serine trial (SENSE trial) ClinicalTrials.gov Identifier: NCT06113055
The Hereditary Sensory Neuropathy Serine trial (SENSE trial) is open to recruitment. This is a randomised double-blind placebo-controlled trial of L-serine in Hereditary Sensory Neuropathy type 1 (HSN1) due to variants in SPTLC1/2 gene.
This is a single-centre study being conducted at the National Hospital for Neurology and Neurosurgery, London UK. The Chief Investigator for this trial is Professor Mary M Reilly. If you have any affected patients who you think may interested in taking part then please invite them to contact the trial team for further information.
Recruitment will close August 2024.
The BPNS wish to facilitate setup of a new charity for peripheral neuropathy in the UK. There is no charity or association in the UK which supports people with all the many causes of peripheral neuropathy. Only a few specific causes of neuropathy have a UK charity, such as CMT-UK, GAIN and Diabetes UK. There is no UK charity to support idiopathic neuropathy, painful small fibre neuropathy (except general pain charities), brachial neuritis, carpal tunnel and entrapment neuropathies, chemotherapy neuropathy (except cancer charities), etc. Several people have come forward to assist with this and work is progressing to get the new charity up and running.